Google TrendGREEN CARD (500+) — Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Pulmonary function and ph" (30 stories)

Top Headline Story

Metabolomics of Right Ventricular Function in Pulmonary Hypertension
Lead StoryAmerican Heart Association Journalsworld
Apr 15

Metabolomics of Right Ventricular Function in Pulmonary Hypertension

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFBJMmVkQzhBYjdxR1NKaXJsdm0tTGFaem9XM2RtUF9qMnRXR2U5b0IzQVg0NF85MmRnV19GQzAxSjRtNzQzazZIaHV3ZEIzRUZuYXM5UnhEcHF6NE1vYWltMHFMbTJ6Mmw4R3lkVG9R?oc=5" target="_blank">Metabolomics of Right Ventricular Function in Pulmonary Hypertension</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Real-time search volume
500+18m ago

green card

Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows

10000+18m ago

power outage near me

LIVE | Atlanta weather: Power outages, tree damage remain as storm threat moves east

1000+18m ago

sony playstation

PS2 Discs Now Load on Jailbroken PS5 Consoles Through PS5SX2 Emulator

100+18m ago

loki

Loki Star Addresses Avengers: Doomsday Return Status After New Tva Post-Credits Scene

Search Results for "Pulmonary function and ph"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Treprostinil shows lasting benefits for children with lung-related PH
Pulmonary Hypertension Newsworld

Treprostinil shows lasting benefits for children with lung-related PH

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxNSUhib0hLSy1UQy1YeUN5eVlSZEhXcHFPeEtSMGM5aHdQQm95eE5zTm9VMTBBUjROanptQlVucWdzNEsxQVBRX3ctV0c0cllacUJBaUFoZ0J3RFpUaS1SSUhiZVJqalJhb2RVRG01N252aEttT2lqd3dSQlVmaEQ0UHNmX0U0TTNFaXdocEFoU3dKQ3IyNTlyWEZ3aDZEV2h5NC0tbmVRTQ?oc=5" target="_blank">Treprostinil shows lasting benefits for children with lung-related PH</a>  <font color="#6f6f6f">Pulmonary Hypertension News</font>

UPDATE - Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
GlobeNewswireworld

UPDATE - Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD

<a href="https://news.google.com/rss/articles/CBMi0AJBVV95cUxORU94bVNKbWJjME1FYUhpT2l6YXczLXVaTXRSSjBiTHNrcVBEb1ZpOWxDZkxrbUtIMlNLY1QyOEhCNGZzYnh6SFNDUFJsSURUQmJseEFoX01RbUhTZzNnWWtpcDVsRXZVRGhIRmZQRnJvbDRMeExXeTF3aGtpREh1cnc2bGhiSmJ0TTNsTlQ1SUNlN2RVY214LTVheGxkSFhtR2x6Zmc5MW9ieFZPTVduZ000b0JPUXdOamtxa2tVVVVpZUVSblBCLTh2MExTejVlVzd6V2JRTV95TnRKTHZwVkNMSXZMSEpwTzNjRml5dDlicEF4ZTNYR2Jrb2lfeWl2Y0d4QjJ1WFZVbEsydktSS2R0SVZDeFM1cDJsUDZkNnFZM2Z1dkU2cXB5aExSWno3OEJkb2JNYmowUGhER1VIQ3pTcWY0aF90QmVOa1lRRHI?oc=5" target="_blank">UPDATE - Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD</a>  <font color="#6f6f6f">GlobeNewswire</font>

Pulmonary function impairment and its relationship with target therapy response in patients with pulmonary arterial hypertension
Frontierstech

Pulmonary function impairment and its relationship with target therapy response in patients with pulmonary arterial hypertension

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNdU9vS2U3Yi14MllIRWl5dkEtWnZVckZRd0lVU1pBSDBEMkwyNlZiNWFTN3N1R3BIbHNPY1NIdmtSb29Zbm1wN1Z3emhDUkpaa0loT19CMFVTWjBMc3pJQU1WaFlUenp5Z0VWaE16ZTVwV2NzTG9ROTNHSGtjUHVPUjhIS2F0VU9WWjQzZ0dn?oc=5" target="_blank">Pulmonary function impairment and its relationship with target therapy response in patients with pulmonary arterial hypertension</a>  <font color="#6f6f6f">Frontiers</font>

Sonye Danoff, M.D., Ph.D., Discusses the FIBRONEER Study for IPF
Managed Healthcare Executivegeneral

Sonye Danoff, M.D., Ph.D., Discusses the FIBRONEER Study for IPF

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxOeUhvN19rOWx2OXE1eTNGeXF1V2MtWjJhX3k4azJUbWpjb3h0LWYzLVh4cGxqRkZ1MlI2NWR3UkhRU2E1RFlfdUtReFNEY19sS2Z5SV9SaW5ualBscy1DZjB2dlhVX3ExQ2hHeVVZRExDV1FFQ29Yd1BwUjJaVFNpRm5NYzRfVFRFeF9wb0x4UUYtaXVnN1RzWUIxWnFST0ZwS25HN25FUGc3UGs?oc=5" target="_blank">Sonye Danoff, M.D., Ph.D., Discusses the FIBRONEER Study for IPF</a>  <font color="#6f6f6f">Managed Healthcare Executive</font>

Implications of Race Adjustment in Lung-Function Equations
The New England Journal of Medicineworld

Implications of Race Adjustment in Lung-Function Equations

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBsQ2ZTSVpaLWxCREdGYTY5UlhQazNwaXdLRDhFMU8zQk5iM2RxODR6ZjVsVTFLbDBqbkhTR29IUk9qaGcyaGRIY0xRODdqMllweHFvdFIxTmdSVDlkZnF3?oc=5" target="_blank">Implications of Race Adjustment in Lung-Function Equations</a>  <font color="#6f6f6f">The New England Journal of Medicine</font>

Adding inhaled LAM-001 to PH-ILD therapy eased symptoms in trial
Pulmonary Hypertension Newsgeneral

Adding inhaled LAM-001 to PH-ILD therapy eased symptoms in trial

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxOTXptYmVxRk1lMGNBREtZZkI2MHVaN3F1VHNqcFd1ZmZhSjNfVk5haXBiQmZ0bURvM2RrTDQ3WmlEVUtFREY3cWw5bW94T1BDSXpZalRoeGFGYUZsQ3RIeFM3YlRxc0RxSlN0QWptTzFXQ1QtOTZhRnZZX2NCcjhJdG1zcTJfalE2YlhqZGtGVmdrSU5OQWlXblQzMGQ2ZlRvWktBOA?oc=5" target="_blank">Adding inhaled LAM-001 to PH-ILD therapy eased symptoms in trial</a>  <font color="#6f6f6f">Pulmonary Hypertension News</font>

Slow, Steady Advances: Noninvasive Diagnosis of PH in ILD Populations
AJMCgeneral

Slow, Steady Advances: Noninvasive Diagnosis of PH in ILD Populations

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxQSWtzcVMtcm03UGpSTEpNVG5fX0k1WjJxZlVka3MyZUcyUjhycURoM09Na2oybGc5QnpUSXlWRllrS0ZzM1hwTS1sOFFEU0pDVXRfdnEyalRfUWJwM1FHRnZUdUwyU2VKRE16MUdyQllXbzF2SUdoanlhcmtyM0d6aVdEcHU0SUlHMGNQaXlWczYtSjgteEJEZQ?oc=5" target="_blank">Slow, Steady Advances: Noninvasive Diagnosis of PH in ILD Populations</a>  <font color="#6f6f6f">AJMC</font>

Nintedanib preserves lung growth and prevents pulmonary hypertension in a hyperoxia-induced lung injury model
Natureworld

Nintedanib preserves lung growth and prevents pulmonary hypertension in a hyperoxia-induced lung injury model

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFAtbk1wc1JNLUNZLUNYbnpMaXZibzlYcGxhejVmbkx6NkhFMHNwMlo3enE2ZmhTMjFWQ3JZa1F2VEdNdUdXTlhMeWdRaC11MF9hMEJTbTFWc1Zrc0s4dXMw?oc=5" target="_blank">Nintedanib preserves lung growth and prevents pulmonary hypertension in a hyperoxia-induced lung injury model</a>  <font color="#6f6f6f">Nature</font>

Pulmonary Hypertension With ILD: Diagnostic and Treatment Challenges
Pulmonology Advisorgeneral

Pulmonary Hypertension With ILD: Diagnostic and Treatment Challenges

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxPU2NVRmh3WUJLRFpGRDhJX2RVX1VENmljQnVyU2pFNnUzdkRpTE9icVpvb0FjdmthZTUtNmRWcGNiQzIzWnJiSlo5MXE2ekFUWFRrb3pFcDdmOF9iR0Fwc3FXamJGQ3hGSGtBelVRZ2ZQOVNzVWpvbktUcFZ6ZjdFS0hiMTFaSVI4UmxkNHBtcFp4Vm8yUE52MnNVQm5zMzZZMkZFVXYzVnZHU2todWkzLWln?oc=5" target="_blank">Pulmonary Hypertension With ILD: Diagnostic and Treatment Challenges</a>  <font color="#6f6f6f">Pulmonology Advisor</font>

Quantitative CT Evaluation of Small Pulmonary Vessels Has Functional and Prognostic Value in Pulmonary Hypertension
RSNA Journalsworld

Quantitative CT Evaluation of Small Pulmonary Vessels Has Functional and Prognostic Value in Pulmonary Hypertension

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE9qSXpZQUEzejVKWVhxX0Q5TTBaYVFxWUJCS2s2dlFQRldEaDNxMHF4NWdQbDBxdlhseUtsX09WcXZIeVY0REdSYTNKaW9CSDgwNXlwZmpqMmFfc0FKWHROZw?oc=5" target="_blank">Quantitative CT Evaluation of Small Pulmonary Vessels Has Functional and Prognostic Value in Pulmonary Hypertension</a>  <font color="#6f6f6f">RSNA Journals</font>

Right Heart Catheterization Accurately Diagnoses Pulmonary Hypertension in Patients With Interstitial Lung Disease: Results From a Long-Term Cohort Study
Wiley Online Libraryworld

Right Heart Catheterization Accurately Diagnoses Pulmonary Hypertension in Patients With Interstitial Lung Disease: Results From a Long-Term Cohort Study

<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5DNmZGZ0VCeE1IaktsSEM0Nlo2bEhIcE8yR3Q2VHRiTjc4aUUxTW9xYkh3TEdmQW1kYUI2UXpOVEhxWUdfSXVORWtXVUZDeXRKRGFPbFRQQUJSVmsyMmJPaHU5QzFXMFdURVMw?oc=5" target="_blank">Right Heart Catheterization Accurately Diagnoses Pulmonary Hypertension in Patients With Interstitial Lung Disease: Results From a Long-Term Cohort Study</a>  <font color="#6f6f6f">Wiley Online Library</font>

Pulmonary hypertension in chronic lung disease and hypoxia - ERS
European Respiratory Societyworld

Pulmonary hypertension in chronic lung disease and hypoxia - ERS

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE9TdkdlUUlSbmVnVDFGWE9DNVhhOFQwV0lTa0xvaHQ2d1JnMi1DckhQWlJmM0dKY3A4aXk2VVUxSjNQcl9TaXZycWY4WndsWUVBbmxLYm9va2J1MGRDcm5UVjdfd2dFRFlTUkpoUmo1Ty1SR1k?oc=5" target="_blank">Pulmonary hypertension in chronic lung disease and hypoxia</a>  <font color="#6f6f6f">ERS - European Respiratory Society</font>

Sotatercept Shows Promise in Group 3 Chronic Lung Disease Pulmonary Hypertension
HCPLiveworld

Sotatercept Shows Promise in Group 3 Chronic Lung Disease Pulmonary Hypertension

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPWm5ZVXpUdTNrTHY5TEtrR1pWdkJZQjZ3YVhJLVpVX1FRWWhyTzhZYW9lRXVpdVJFdHFSWFlPYmprRlFPZGNEbTVRb0t2aU1EWWdxWC1ENklXYVZ0cExvV29vSThFczF2X1lGeTR3RFUwaW1hUHhoV3BZWHpZWlpYc002Rnd5REVfVElzUGRuUnZCc1JmbXdnNDNNdE44OGZwU0E?oc=5" target="_blank">Sotatercept Shows Promise in Group 3 Chronic Lung Disease Pulmonary Hypertension</a>  <font color="#6f6f6f">HCPLive</font>

Group 3 Pulmonary Hypertension: From Bench to Bedside
American Heart Association Journalsgeneral

Group 3 Pulmonary Hypertension: From Bench to Bedside

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE03WmY0VjJYYmJCVkZ2MXlWNHd0U2FsSDRkaFJ0Mmdad1B5OUk1X0t6cXBUMEEwMF9QM3NVVHZfZWRSc2hscmU3ZHJONTN6akdfQmcwZVpObXdCZy1aY0NzaWtvaWtDNW1JcFVrbDR3?oc=5" target="_blank">Group 3 Pulmonary Hypertension: From Bench to Bedside</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Inhaled Treprostinil and Lung Function in Patients With PH-ILD and PAH
Pulmonology Advisorworld

Inhaled Treprostinil and Lung Function in Patients With PH-ILD and PAH

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQM1ZzM0w5eVZyczBnOEJuRG91UFEyU1VNZU5sbGZoazBUZXB1N25SbEV5UWFUYWFqQk9oc2h3UkMtVmRGOW1Ed3NPS0xJNTR1X2xZbGN5YmRteE9ENFJaX2d1UWJhX3dKZEhRUDN1RUZ2MDhfR2xvMUw5aXBjeXFCZ3FwQllBa0IyYjdhekd4ZzdYRkg5ZGdvZjVWOWNyY0F4M1ZHTVFPcExqZkpxZERTZQ?oc=5" target="_blank">Inhaled Treprostinil and Lung Function in Patients With PH-ILD and PAH</a>  <font color="#6f6f6f">Pulmonology Advisor</font>

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - Group 3 Pulmonary Hyperte
Wiley Online Libraryworld

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - Group 3 Pulmonary Hyperte

<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5BbEdWR1YteW54dERvMFN3M3FqNHBpeTJvVGJKMlpOeF96ZVNPZFREZVhrM2NnUE1tZlRPVzdpY0pNU3NmWnVKV0N1RDRGbTgwb253Q1B3Sm1ZTlZ5Y1oyTFdFekdVcXJrcmtn?oc=5" target="_blank">Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - Group 3 Pulmonary Hyperte</a>  <font color="#6f6f6f">Wiley Online Library</font>

Construction of an early diagnostic model for pulmonary hypertension based on aging-related signature genes and identification of potential therapeutic targets
Naturegeneral

Construction of an early diagnostic model for pulmonary hypertension based on aging-related signature genes and identification of potential therapeutic targets

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBNWTBUU09XWkkzRlNuY0QzdktpWS0zUUpvMUhsS3ZwT19kM0pITjcwMzlIVkFUalAxSm5JZ0hIdnhDdUdyeDlPSUZnYm1fdnZTb3ZhaEl3Z3k1QXdwSzhV?oc=5" target="_blank">Construction of an early diagnostic model for pulmonary hypertension based on aging-related signature genes and identification of potential therapeutic targets</a>  <font color="#6f6f6f">Nature</font>

Tyvaso Improves Lung Function in PH-ILD Patients, New Trial Data Show
Pulmonary Hypertension Newsworld

Tyvaso Improves Lung Function in PH-ILD Patients, New Trial Data Show

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNNXdQSDV1SXhzZFdWOUpDMjNUSWZVVDRhMmZrT1hmcmt3eXNuLVBlcWM2NklvZEVfQkpfYXBST0Z2UGNjaFB4SHk1UFJScnA2NDhvNjJLMDQyVkdfcUc3MjVORmwxQzdHbXY1emdXRkJwc2xNSEFXZGJ2VV8zRC1IQ05aY1lDVm9fWkNSd3pFNVd4MXVyOUZoaGxUOWtNbG1yclVJVGZzLWJuY1oyUURReTBVVXpMYUlWQ1czZQ?oc=5" target="_blank">Tyvaso Improves Lung Function in PH-ILD Patients, New Trial Data Show</a>  <font color="#6f6f6f">Pulmonary Hypertension News</font>

ILD Associated with PH Linked to Worse Survival Outcomes in Study
Pulmonary Hypertension Newsgeneral

ILD Associated with PH Linked to Worse Survival Outcomes in Study

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxOS05VaS11el9tMWhxc24xWTI1bEp1TEpfS2RHVDVjeVJoaUtDTDBaczZob3BmZlVWeGVGS09wdHZKeEhwQU95b0FyZjd3SW1aUEJmWXNnMHZkZDYwbFE5Vk5kbnczV0NweXlYZ3dLYkQ2NDdHT2NEMlY3UWo4cVhsQnlYQnVaR1o1NkNGb1BGSHdKaTZxSi0yejcyZU1OMEdTLU5uOElZcU51MFBScWpQY3Uwb1FiQzZt?oc=5" target="_blank">ILD Associated with PH Linked to Worse Survival Outcomes in Study</a>  <font color="#6f6f6f">Pulmonary Hypertension News</font>

History of Tuberculosis Treatment Tied to High Risk of PH in Study...
Pulmonary Hypertension Newsgeneral

History of Tuberculosis Treatment Tied to High Risk of PH in Study...

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxOZ29xaGh5VFh5NWtXZUpBR0c0bmFMNnBrcmhST0kyb2pRUjF0NUcxM0d6eTVmRDFEYnFmTDNCZFhSTXEzVC1tbUhkQUZySTMtNGwxNjllYU9QWk5RMzJlUHVDUWxMeVhsQnBkNnQzUVJMSnh4aUF5Wk1uT1A5ZmNRR1g1bnNhczd1TEVaWXhrRzllUzJxNndkTmJ6d2l6N3c?oc=5" target="_blank">History of Tuberculosis Treatment Tied to High Risk of PH in Study...</a>  <font color="#6f6f6f">Pulmonary Hypertension News</font>

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
NEJMworld

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE14UVlpZ01RQlk5dHhvbEJDdWVSdm5vLUlpSUE4djFNc0JTS0ZRVGRxaFU2WTAzY2s2c0IzeXZ0NnBYT0t0cWE5LTBQSTZIT3l0VW1yaWhqT25mRmhlR0pJNw?oc=5" target="_blank">Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease</a>  <font color="#6f6f6f">NEJM</font>

Treg Cells Attenuate Pulmonary Venous Remodeling in PH-LHD via NLRC3 Signaling | Circulation Research
American Heart Association Journalsgeneral

Treg Cells Attenuate Pulmonary Venous Remodeling in PH-LHD via NLRC3 Signaling | Circulation Research

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1wZWFRa21aUTY1UFJRMm9UQjRVWFZ6bWk2WkxqNnlrZmVUQzVkT0pVazdVN28tNWtEbVBUNnVWbHQ2Rll0UFR6TW4wYTRKal9oMGpJaTVwbWZxVzF2UXlVUlVOb3JqbWtGMURDYWpR?oc=5" target="_blank">Treg Cells Attenuate Pulmonary Venous Remodeling in PH-LHD via NLRC3 Signaling | Circulation Research</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Impact of Systemic Sclerosis–Associated Interstitial Lung Disease, With and Without Pulmonary Hypertension, on Survival: A Systematic Review
Cureusworld

Impact of Systemic Sclerosis–Associated Interstitial Lung Disease, With and Without Pulmonary Hypertension, on Survival: A Systematic Review

<a href="https://news.google.com/rss/articles/CBMihwJBVV95cUxPeVJhSjZuYW5KSE5sV2pRRlU1RUFhWTFYZEx3TUYwbHBYRjBPNFJxekxFLVZLU1Y0LWZqR2tmazJRX0w3eUdYRnBDVlFRNEo2ZzUxbEpKMTlROU9VNzNRR25kSzkzX0xnZDhFb0cyQ3BQamVTdlJmbnBaVl9yWjJWbU5LcWpham5iWFZ2TXNNMEVTY2Z3azJtQ2gwMnJ1LVJ2QzUyazAtOWxFUzYwb3N6U3BXeGpycTRFMWVZaDV2VjNxMUtCRTRJS0dwYnNRZS1aUUhTUUZ6aEVjUVd1YmxkdFR6VF9BcnY1TDJqcE1WeXRGVENtMTduTGcxYU1QZHBDMjJxNEZ3dw?oc=5" target="_blank">Impact of Systemic Sclerosis–Associated Interstitial Lung Disease, With and Without Pulmonary Hypertension, on Survival: A Systematic Review</a>  <font color="#6f6f6f">Cureus</font>

The role of vitamin D in chronic obstructive pulmonary disease with pulmonary hypertension
Wiley Online Librarygeneral

The role of vitamin D in chronic obstructive pulmonary disease with pulmonary hypertension

<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBNNWRCU3FyU29jemVXRElfdnZXemJKcVdnZzlQRTJ4bmp2ZGlSQ1QwWWdUcDAtNzU4S19lUVJGcklhVnNDN2hYTGlOZDcyQjdwTjU1R2FVdG9UOUVreW1vV0x1Z2dILTNCV2xB?oc=5" target="_blank">The role of vitamin D in chronic obstructive pulmonary disease with pulmonary hypertension</a>  <font color="#6f6f6f">Wiley Online Library</font>

Association of FVC/DLCO with pulmonary hypertension risk and interstitial disease in systemic sclerosis patients - ERS
European Respiratory Societygeneral

Association of FVC/DLCO with pulmonary hypertension risk and interstitial disease in systemic sclerosis patients - ERS

<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxPOWFzZ2ZjaU9XajJhUmV2bWNpUVFKM054MXQ1cU1MeElDTVVMOFQ3VGhUMHNhZHhQVm5BbHpDXzRwMGtqODFoSVZDSGhWTXhoU1pMazNXWTBuVjZEM1F5em5taWRXbE53amREby1qYVJKUm9vLXBVMWVtZm90XzU5Q2tFaw?oc=5" target="_blank">Association of FVC/DLCO with pulmonary hypertension risk and interstitial disease in systemic sclerosis patients</a>  <font color="#6f6f6f">ERS - European Respiratory Society</font>

Successful Management of HFpEF-Related Pulmonary Hypertension With Systemic-Level Pressures Using Sacubitril-Valsartan and Empagliflozin
JACC Journalsgeneral

Successful Management of HFpEF-Related Pulmonary Hypertension With Systemic-Level Pressures Using Sacubitril-Valsartan and Empagliflozin

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE9sYk13NmQ3ekhKM1ZLY1l4VWptbWkxbjllNGZFeGlZZmtCWUpHc0tvTkNwWWk4QktmdWx4YXE2bEFCdmE4MURpcms3cVhWcThTZnJBNHdndWNnU0pLeTNUSDA5MVJKZGY4MXc?oc=5" target="_blank">Successful Management of HFpEF-Related Pulmonary Hypertension With Systemic-Level Pressures Using Sacubitril-Valsartan and Empagliflozin</a>  <font color="#6f6f6f">JACC Journals</font>

Oxygenated hemoglobin as prognostic marker among patients with systemic sclerosis screened for pulmonary hypertension
Naturegeneral

Oxygenated hemoglobin as prognostic marker among patients with systemic sclerosis screened for pulmonary hypertension

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE12WVhhZVpJWnEtX1hLWlEtWlNBYjRjbU5tNDNMWUoyNHQtbXllUHpwUFY3UFZfUk5Cc25xUS13OW12aFR2c1liWm9ESUR6YW1LTmNxYVZJbmRjOUhnR3l3?oc=5" target="_blank">Oxygenated hemoglobin as prognostic marker among patients with systemic sclerosis screened for pulmonary hypertension</a>  <font color="#6f6f6f">Nature</font>

Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension | Scientific Reports
Naturegeneral

Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension | Scientific Reports

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9iZHBVNkduYjhLWnc4dndaMkE5TmlxZEhXSU5aWlV6NzBURXAxdTFVdURPZ2VPQ3g5bHNkNGtHYS1IWGoxTndWWlJ6QWJTakc1LXhPUmhBeHRBdVRlaFFZ?oc=5" target="_blank">Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension | Scientific Reports</a>  <font color="#6f6f6f">Nature</font>

Current Therapeutic Approaches for Adults With WHO Group 1 Pulmonary Arterial Hypertension
Pulmonology Advisorgeneral

Current Therapeutic Approaches for Adults With WHO Group 1 Pulmonary Arterial Hypertension

<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxPYmFrSUhjcEVmQ3NQWW13NHlCcEZPSWh3WWk0Q0pPd1R5S0lkR291UWRERkFfM1lzTkw3TnFTSWM4NzdzQXdGY1FBS2QyYzI4WTh2QThLZ2RrWW9IbWVxMG82akVLSkdNMUVTaVlHOU9PTTducC1vdDR3Ukl5cWNzeThWMTJ6NUxQUm1wVzVpbWdqYmthdEpQX1VvWlRXTUVyUDR6QWlOMnJwcmtfcHAwbTFfMkM0ampOekhnWFZDX3FDeDNfblFlNW1B?oc=5" target="_blank">Current Therapeutic Approaches for Adults With WHO Group 1 Pulmonary Arterial Hypertension</a>  <font color="#6f6f6f">Pulmonology Advisor</font>

"Pulmonary function and ph" — Live Google News Trends & Headlines